FDA Inspection 1171793 — Karl Storz Endovision, Inc.

Karl Storz Endovision, Inc. — FEI 1221826

The FDA completed an inspection of Karl Storz Endovision, Inc. on June 14, 2022 in Charlton, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 14, 2022
Fiscal Year
2022
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Charlton, MA (United States)

Citations

IDCFRDescription
367821 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate